Department of Surgery, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Department of Nutrition and Dietetics, Auckland City Hospital, Auckland, New Zealand.
JPEN J Parenter Enteral Nutr. 2020 Feb;44(2):182-196. doi: 10.1002/jpen.1679. Epub 2019 Jul 26.
Gastrointestinal dysfunction/failure (GDF) is a common feature of critical illness. There is no consensus on the best way to measure severity of GDF. The aim of this systematic review was to evaluate and compare all gastrointestinal dysfunction scoring tools (GDSTs) to determine aspects that might be useful to construct a new gut scoring tool for intensive care patients. A comprehensive database search of MEDLINE and EMBASE on GDSTs in acute, surgical, and critically ill patients was conducted. Extraction of data was conducted for study characteristics, GDST domains, feasibility of the scoring process, clinical outcomes, and quality of life attributes; independent authors conducted the search, applied the selection criteria, and extracted the data. Methodological quality of studies was assessed. A GDST matrix was created using 14 scoring tools and was evaluated for validity. The 14 GDSTs identified were used in different clinical settings, including critical illness, acute intestinal failure, gastrointestinal disorders, and postoperative patients. There was marked variation between these GDSTs. There is a lack of emphasis in the use of objective laboratory parameters and gut-specific biomarkers to measure GDF in majority of the studies. The overall quality of evidence was poor, and most tools lacked formal validation. This review has highlighted the lack of an agreed and validated approach to scoring GDF in critical illness. The identified aspects of GDF relevant to critical illness should now be incorporated in a new scoring tool and prospectively tested in intensive care patients.
胃肠道功能障碍/衰竭(GDF)是危重病的常见特征。目前尚无关于测量 GDF 严重程度的最佳方法的共识。本系统评价的目的是评估和比较所有胃肠道功能障碍评分工具(GDST),以确定可能有助于为重症监护患者构建新的肠道评分工具的方面。对 MEDLINE 和 EMBASE 数据库进行了全面检索,以查找急性、外科和危重病患者的 GDST。独立作者进行了搜索、应用选择标准和提取数据;研究特征、GDST 领域、评分过程的可行性、临床结局和生活质量属性。对研究的方法学质量进行了评估。使用 14 种评分工具创建了 GDST 矩阵,并对其进行了有效性评估。确定的 14 种 GDST 用于不同的临床环境,包括危重病、急性肠衰竭、胃肠道疾病和术后患者。这些 GDST 之间存在明显差异。大多数研究中缺乏使用客观实验室参数和肠道特异性生物标志物来测量 GDF 的重点。证据的总体质量较差,大多数工具缺乏正式验证。本综述强调了目前缺乏一种针对危重病的公认和经过验证的 GDF 评分方法。目前应将与危重病相关的 GDF 相关方面纳入新的评分工具,并在重症监护患者中进行前瞻性测试。